Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 01, 2016
Gilead Sciences has announced that, effective March 10, 2016, current Chairman and CEO John C. Martin, PhD will assume the role of Executive Chairman of the company. John F. Milligan, PhD, currently President and Chief Operating Officer, will be ...
read more
GI Partners, a private investment firm, announced it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses from Charles River Laboratories International, Inc., forming Rose ...
read more
Thursday, August 27, 2020
GI Partners has completed the previously announced acquisition of Clinical Ink, a global clinical trial technology company.
read more
Tuesday, November 08, 2022
Global Healthcare Opportunities, or GHO Capital Partners LLP and The Vistria Group announced that they have entered into a definitive agreement to acquire a controlling interest in Alcami Corporation from funds affiliated with Madison Dearborn ...
read more
Wednesday, December 02, 2015
GHO Capital, a European specialist healthcare investor, has announced the acquisition of Quotient Clinical, a provider of outsourced, early-stage drug development services to the pharmaceutical industry.
read more
Thursday, November 18, 2021
Global Healthcare Opportunities, or GHO Capital Partners LLP, has announced the acquisition of Genesis Research, a provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services.
read more
Wednesday, January 22, 2020
GHO has acquired Ardena, a specialist CDMO focused on early phase drug development.
read more
Friday, December 20, 2019
Getinge announced an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V.
read more
Gerresheimer announced investments to rapidly expand manufacturing, supply and logistics capacity for glass vials in the U.S. The project will be supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
read more
Gerresheimer AG is planning to build a new plant in Skopje, Republic of North Macedonia.
read more
The company created bioGO in response to limited and rigid infrastructure options for launching biopharmaceutical projects.
read more
Richter-Helm BioLogics GmbH & Co. KG has announced the start of construction for an expansion project at its cGMP manufacturing facility in Bovenau, Germany.
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Thursday, January 14, 2021
GeoVax Labs announced the NIAID, part of the NIH, has awarded the Company a SBIR grant in support of its development of a vaccine against SARS-CoV-2.
read more
George Clinical announced it has rebranded to become Emerald Clinical Trials. This strategic name change underscores the company's well-established position as a dedicated, reliable, consistent, and flexible CRO, while mitigating global clinical ...
read more